Dermatomyositis related to the relapse of cervical cancer

Dermatomyositis (DM) is a rare syndrome which belongs to the group of idiopathic inflammatory myopathies (IIM). The diagnosis of DM in adults is an indication for diagnostic evaluation towards malignancy. The exacerbation of clinical symptoms or laboratory markers of DM may indicate the relapse of neoplasm, therefore close follow-up visits of patients are obligatory. We present the case of a woman with a two-month history of progressive muscle weakness, dysphagia and oedemo-erythematous skin lesions limited to the face and trunk. The patient was diagnosed with DM associated with the relapse of cervical cancer.

[1]  G. Chen,et al.  Meta‐analysis of the association of dermatomyositis and polymyositis with cancer , 2013, The British journal of dermatology.

[2]  L. Punzi,et al.  Autoantibodies in Polymyositis and Dermatomyositis , 2013, Current Rheumatology Reports.

[3]  Ganesh P. Dhavalshankh,et al.  CUTANEOUS MANIFESTATIONS OF DERMATOMYOSITIS IN MALE PATIENT: A RARE REPORT , 2013 .

[4]  L. Caminal-Montero,et al.  Clinical associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies: Diagnostic utility of their separate detection , 2013, Autoimmunity.

[5]  A. Pestronk.  Acquired immune and inflammatory myopathies: pathologic classification , 2011, Current opinion in rheumatology.

[6]  Y. Yamasaki,et al.  Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis , 2011, Modern rheumatology.

[7]  A. Baer,et al.  Malignancy in Myositis , 2011, Current rheumatology reports.

[8]  H. Kern,et al.  Polymyositis, dermatomyositis and malignancy: a further intriguing link. , 2010, Autoimmunity reviews.

[9]  Wei Zhang,et al.  Dermatomyositis and malignancy: a retrospective study of 115 cases. , 2009, European review for medical and pharmacological sciences.

[10]  M. Fujimoto,et al.  Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. , 2007, Rheumatology.

[11]  I. Targoff,et al.  A novel autoantibody to a 155-kd protein is associated with dermatomyositis. , 2006, Arthritis and rheumatism.

[12]  P. Grenier,et al.  Tumor Antigen Markers for the Detection of Solid Cancers in Inflammatory Myopathies , 2005, Cancer Epidemiology Biomarkers & Prevention.

[13]  R. Hohlfeld,et al.  Polymyositis and dermatomyositis , 2003, The Lancet.

[14]  J. Callen.  When and how should the patient with dermatomyositis or amyopathic dermatomyositis be assessed for possible cancer? , 2002, Archives of dermatology.

[15]  B. Engelen,et al.  Clinical and serological characteristics of 125 Dutch myositis patients , 2002, Journal of Neurology.

[16]  David T Felson,et al.  Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study , 2001, The Lancet.